58
Participants
Start Date
April 30, 1999
Primary Completion Date
June 30, 2012
Study Completion Date
June 30, 2012
5-Fluoro-2-Deoxycytidine (FdCyd)
Given PO and IV
Laboratory Biomarker Analysis
Correlative Studies
Pharmacological Study
Correlative Studies
Tetrahydrouridine (THU)
Given PO and IV
National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda
USC/Norris Comprehensive Cancer Center, Los Angeles
City of Hope National Medical Center, Duarte
University of California, Davis Cancer Center, Sacramento
National Cancer Institute (NCI)
NIH
City of Hope Medical Center
OTHER